stockrowZimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.
- Revenue
- +3.07%
- EPS
- −13.5%
- Free cash flow
- +29.8%
- Total debt
- −7.50%
Quarter to September 2026, against a year earlier
Follow ZBH
Alert me
Zimmer Biomet Holdings, Inc. (ZBH) Shares outstanding
Zimmer Biomet Holdings, Inc.'s shares outstanding at the end of fiscal 2025 was $198.7M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $191.4M. Over the past ten years it has ranged from $189.8M (fiscal 2015) to $210.4M (fiscal 2021); the current reading is higher than 18% of that period. Zimmer Biomet Holdings, Inc. ranks 18th of 147 Medical Devices companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $198.7M | (2.55%) |
| FY2024 | $203.9M | (2.77%) |
| FY2023 | $209.7M | (0.29%) |
| FY2022 | $210.3M | (0.05%) |
| FY2021 | $210.4M | 1.64% |
| FY2020 | $207.0M | 0.15% |
| FY2019 | $206.7M | 1.57% |
| FY2018 | $203.5M | (0.10%) |
| FY2017 | $203.7M | 0.64% |
| FY2016 | $202.4M | 6.64% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $191.4M | (0.73%) |
| Jun 2026 | $192.8M | (1.53%) |
| Mar 2026 | $195.8M | (1.46%) |
| Dec 2025 | $198.7M | (0.05%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| PHG Koninklijke Philips N.V. compare | $989.9M |
| SNN Smith & Nephew SNATS, Inc. compare | $449.4M |
| DXCM DexCom, Inc. compare | $383.5M |
| ZBH Zimmer Biomet Holdings, Inc. | $191.4M |
| GMED Globus Medical, Inc. compare | $136.0M |
| STE STERIS plc compare | $97.6M |
| PODD Insulet Corporation compare | $69.5M |
| GKOS Glaukos Corporation compare | $61.2M |
| PEN Penumbra, Inc. compare | $39.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on ZBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement